The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 50 | — | 20.1x | Near average | |
Growth | 59 | 29.3% | 5.6% | Near average | |
Quality | 33 | -87.1% | 7.6% | Below average | |
Safety | 38 | 2.3x | 0.4x | Near average | |
Capital Return | 40 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
PROCEPT BioRobotics Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy PROCEPT BioRobotics Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
PRCT stock experienced a 5.07% decline in its average price target over the past 30 days, as the consensus dropped from $42.4 to $40.25 despite the number of analysts remaining constant. This downward adjustment reflects caution regarding previous high valuations, noting a sharp dispersion in forecasts, where the gap between the high ($62) and low ($30) estimates exceeds 100%, indicating uncertainty regarding the pace of future revenue growth.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.